Drugs & Therapy Perspectives

, Volume 12, Issue 5, pp 8–10 | Cite as

Corticosteroid therapy still the mainstay for polymyalgia rheumatica and giant cell arteritis

New Drugs and Disease Management
  • 7 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Salvarani C, Macchioni L, Olivieri I, et al. Diagnosis and management of polymyalgia rheumatica/giant cell arteritis. BioDrugs 1998 Jan; 9(1): 25–32PubMedCrossRefGoogle Scholar
  2. 2.
    Chung T-Y, Hunder GG, Ilstrup DM, et al. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672–80Google Scholar
  3. 3.
    Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984; 13: 322–8PubMedCrossRefGoogle Scholar
  4. 4.
    Bird HA, Esselinckx W, Dixon ASJ, et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434–9PubMedCrossRefGoogle Scholar
  5. 5.
    Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122–8PubMedCrossRefGoogle Scholar
  6. 6.
    McCarty DJ, O’Duffy JD, Pearson L, et al. Remitting seronegative symmetrical synovitis with pitting edema: RS3PE syndrome. JAMA 1985; 254: 2763–7PubMedCrossRefGoogle Scholar
  7. 7.
    Helfgott SM, Kieval RI. Polymyalgia rheumatica inpatients with a normal erythrocyte sedimentation rate. Arthritis Rheum 1996; 39: 304–7PubMedCrossRefGoogle Scholar
  8. 8.
    Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C-reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis. Ann Rheum Dis 1989; 48: 667–71PubMedCrossRefGoogle Scholar
  9. 9.
    Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol 1994; 21: 1283–6PubMedGoogle Scholar
  10. 10.
    Sunku J, Gabriel SE, Salvarani C, et al. Long-term outcome of anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. In pressGoogle Scholar
  11. 11.
    Ferraccioli GF, Salaffi F, De Vita S, et al. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 1996; 23: 624–8PubMedGoogle Scholar
  12. 12.
    Van der Veen MJ, Dinant HJ, van Booma-Frankfort C, et al. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 1996; 55: 218–23PubMedCrossRefGoogle Scholar

Copyright information

© Adis lnternational Limited 1998

Personalised recommendations